These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2418156)

  • 41. Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts.
    Spagnolo A; Glick RP; Lin H; Cohen EP; Feinstein DL; Lichtor T
    J Neurosurg; 2007 Feb; 106(2):299-305. PubMed ID: 17410715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical evaluation of benzoporphyrin derivative combined with a light-emitting diode array for photodynamic therapy of brain tumors.
    Schmidt MH; Reichert KW; Ozker K; Meyer GA; Donohoe DL; Bajic DM; Whelan NT; Whelan HT
    Pediatr Neurosurg; 1999 May; 30(5):225-31. PubMed ID: 10461068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
    Kim CK; Han JH
    J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells.
    Li XT; Tang W; Jiang Y; Wang XM; Wang YH; Cheng L; Meng XS
    Oncotarget; 2016 Apr; 7(17):24604-22. PubMed ID: 27029055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study.
    Hercbergs AA; Goyal LK; Suh JH; Lee S; Reddy CA; Cohen BH; Stevens GH; Reddy SK; Peereboom DM; Elson PJ; Gupta MK; Barnett GH
    Anticancer Res; 2003; 23(1B):617-26. PubMed ID: 12680157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Value of chemotherapy associated with conventional treatment of malignant gliomas of the brain. Study of 95 cases with histological verification and follow-up of 1 to 6 years 9 months].
    Paillas JE; Prince MA; Hassoun J; Pellet W; Peragut JC
    Rev Neurol (Paris); 1979 Mar; 135(3):251-62. PubMed ID: 227020
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacokinetics, pharmacodynamics, safety and tolerability of APG101, a CD95-Fc fusion protein, in healthy volunteers and two glioma patients.
    Tuettenberg J; Seiz M; Debatin KM; Hollburg W; von Staden M; Thiemann M; Hareng B; Fricke H; Kunz C
    Int Immunopharmacol; 2012 May; 13(1):93-100. PubMed ID: 22446296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.
    Saito R; Krauze MT; Noble CO; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
    Neuro Oncol; 2006 Jul; 8(3):205-14. PubMed ID: 16723630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of recurrent malignant gliomas with 13-cis-retinoic acid naphthalene triazole.
    Jia PF; Gu WT; Zhang WF; Li F
    Neurol Sci; 2015 May; 36(5):717-21. PubMed ID: 25560534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of intra-arterial and local administration of MCNU on cerebral malignant gliomas].
    Watanabe M; Takeda N; Tanaka R
    Gan To Kagaku Ryoho; 1995 May; 22(6):811-4. PubMed ID: 7755390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats.
    Wang XY; Ishida T; Ichihara M; Kiwada H
    J Control Release; 2005 May; 104(1):91-102. PubMed ID: 15866337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma.
    Wen PY; Omuro A; Ahluwalia MS; Fathallah-Shaykh HM; Mohile N; Lager JJ; Laird AD; Tang J; Jiang J; Egile C; Cloughesy TF
    Neuro Oncol; 2015 Sep; 17(9):1275-83. PubMed ID: 26019185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy.
    Siegal T; Horowitz A; Gabizon A
    J Neurosurg; 1995 Dec; 83(6):1029-37. PubMed ID: 7490617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomycin.
    Hait WN; Gesmonde JF; Lazo JS
    Anticancer Res; 1994; 14(5A):1711-21. PubMed ID: 7531409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood-based biomarkers for the diagnosis and monitoring of gliomas.
    Zachariah MA; Oliveira-Costa JP; Carter BS; Stott SL; Nahed BV
    Neuro Oncol; 2018 Aug; 20(9):1155-1161. PubMed ID: 29746665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Role of chemotherapy in long-term survival of malignant glioma (author's transl)].
    Takeuchi K
    No Shinkei Geka; 1975 Oct; 3(10):815-20. PubMed ID: 55987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The combined treatment of malignant gliomas with various chemotherapeutics administered simultaneously.
    Zettner S
    Minerva Neurochir; 1969; 13(3):251-3. PubMed ID: 4315379
    [No Abstract]   [Full Text] [Related]  

  • 58. Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
    Wen PY; Yung WK; Lamborn KR; Dahia PL; Wang Y; Peng B; Abrey LE; Raizer J; Cloughesy TF; Fink K; Gilbert M; Chang S; Junck L; Schiff D; Lieberman F; Fine HA; Mehta M; Robins HI; DeAngelis LM; Groves MD; Puduvalli VK; Levin V; Conrad C; Maher EA; Aldape K; Hayes M; Letvak L; Egorin MJ; Capdeville R; Kaplan R; Murgo AJ; Stiles C; Prados MD
    Clin Cancer Res; 2006 Aug; 12(16):4899-907. PubMed ID: 16914578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
    Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I
    Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.